Literature DB >> 23948661

Course of irritability, depression and apathy in Huntington's disease in relation to motor symptoms during a two-year follow-up period.

Erik van Duijn1, Nanda Reedeker, Erik J Giltay, Daniëlle Eindhoven, Raymund A C Roos, Rose C van der Mast.   

Abstract

BACKGROUND: Irritability, depression and apathy are frequently reported neuropsychiatric symptoms of Huntington's disease (HD).
OBJECTIVE: This study investigated the course of irritability, depression and apathy in HD during a 2-year follow-up period.
METHODS: In 121 HD mutation carriers the presence of irritability, depression and apathy was measured with the Problem Behaviours Assessment (PBA). Multivariate linear regression analysis was performed to assess their relationships with the change of the motor score of the Unified Huntington's Disease Rating Scale (UHDRS-m) in premotor symptomatic (n = 46) and motor symptomatic mutation carriers (n = 75).
RESULTS: The median depression score of all participants decreased (p = 0.002), whereas irritability and apathy scores did not change significantly. In the total group of mutation carriers, a borderline significant association was found between an increase in motor symptoms and an increase in irritability (p = 0.05), and a trend was found for the association between an increase in motor symptoms and a decrease in depression (p = 0.06). Only in the at baseline premotor symptomatic mutation carriers was an increase in motor symptoms significantly related to an increase in irritability (p = 0.02).
CONCLUSION: An increase in motor symptoms in the at baseline premotor symptomatic mutation carriers is related to an increase in irritability, which may be an early and sensitive marker for disease progression.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23948661     DOI: 10.1159/000343210

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  14 in total

1.  Measurement of Irritability in Cancer Patients.

Authors:  Amy Y Zhang; Stephen J Ganocy
Journal:  Nurs Res       Date:  2020 Mar/Apr       Impact factor: 2.381

2.  Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias.

Authors:  Heike Jacobi; Sophie Tezenas du Montcel; Peter Bauer; Paola Giunti; Arron Cook; Robyn Labrum; Michael H Parkinson; Alexandra Durr; Alexis Brice; Perrine Charles; Cecilia Marelli; Caterina Mariotti; Lorenzo Nanetti; Lidia Sarro; Maria Rakowicz; Anna Sulek; Anna Sobanska; Tanja Schmitz-Hübsch; Ludger Schöls; Holger Hengel; Laszlo Baliko; Bela Melegh; Alessandro Filla; Antonella Antenora; Jon Infante; José Berciano; Bart P van de Warrenburg; Dagmar Timmann; Sandra Szymanski; Sylvia Boesch; Wolfgang Nachbauer; Jun-Suk Kang; Massimo Pandolfo; Jörg B Schulz; Audrey Tanguy Melac; Alhassane Diallo; Thomas Klockgether
Journal:  J Neurol       Date:  2018-06-29       Impact factor: 4.849

3.  Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.

Authors:  Noelle E Carlozzi; Siera Goodnight; Anna L Kratz; Julie C Stout; Michael K McCormack; Jane S Paulsen; Nicholas R Boileau; David Cella; Rebecca E Ready
Journal:  J Huntingtons Dis       Date:  2019

4.  Relationships Among Apathy, Health-Related Quality of Life, and Function in Huntington's Disease.

Authors:  Nora E Fritz; Nicholas R Boileau; Julie C Stout; Rebecca Ready; Joel S Perlmutter; Jane S Paulsen; Kimberly Quaid; Stacey Barton; Michael K McCormack; Susan L Perlman; Noelle E Carlozzi
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2018-03-21       Impact factor: 2.198

5.  Structural brain correlates of irritability and aggression in early manifest Huntington's disease.

Authors:  Saul Martinez-Horta; Frederic Sampedro; Andrea Horta-Barba; Jesús Perez-Perez; Javier Pagonabarraga; Beatriz Gomez-Anson; Jaime Kulisevsky
Journal:  Brain Imaging Behav       Date:  2021-02       Impact factor: 3.978

6.  Non-motor symptoms in Huntington's disease: a comparative study with Parkinson's disease.

Authors:  Tatiana Aldaz; Pasquale Nigro; Almudena Sánchez-Gómez; Celia Painous; Lluís Planellas; Pilar Santacruz; Ana Cámara; Yaroslau Compta; Francesc Valldeoriola; Maria J Martí; Esteban Muñoz
Journal:  J Neurol       Date:  2019-03-05       Impact factor: 4.849

7.  Counterfactual Thinking Deficit in Huntington's Disease.

Authors:  Federica Solca; Barbara Poletti; Stefano Zago; Chiara Crespi; Francesca Sassone; Annalisa Lafronza; Anna Maria Maraschi; Jenny Sassone; Vincenzo Silani; Andrea Ciammola
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

Review 8.  Risk-taking and pathological gambling behavior in Huntington's disease.

Authors:  Carla Kalkhoven; Cor Sennef; Ard Peeters; Ruud van den Bos
Journal:  Front Behav Neurosci       Date:  2014-04-02       Impact factor: 3.558

9.  Irritability in Huntington's Disease: Factor Analysis of Snaith's Irritability Scale.

Authors:  John Maltby; Maria Dale; Mandy Underwood; Jane Simpson
Journal:  Mov Disord Clin Pract       Date:  2016-10-01

10.  Responsiveness to change over time and test-retest reliability of the PROMIS and Neuro-QoL mental health measures in persons with Huntington disease (HD).

Authors:  Noelle E Carlozzi; Nicholas R Boileau; Matthew W Roché; Rebecca E Ready; Joel S Perlmutter; Kelvin L Chou; Stacey K Barton; Michael K McCormack; Julie C Stout; David Cella; Jennifer A Miner; Jane S Paulsen
Journal:  Qual Life Res       Date:  2020-08-19       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.